why choose us

First received: March 23, 2023

Clinical Trial: Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Central Nervous System Neoplasms

Study Type: INTERVENTIONAL


Official Title: Loc3CAR: Locoregional Delivery of B7-H3-specific Chimeric Antigen Receptor Autologous T Cells for Pediatric Patients With Primary CNS Tumors

Brief Summary: Loc3CAR is a Phase I clinical trial evaluating the use of autologous B7-H3-CAR T cells for participants ? 21 years old with primary CNS neoplasms.B7-H3-CAR T cells will be locoregionally administered via a CNS reservoir catheter.Study participants will be divided into two cohorts: cohort A with B7-H3-positive relapsed/refractory non-brainstem primary CNS tumors, and cohort B with brainstem high-grade neoplasms.Participants will receive six (6) B7-H3-CAR T cell infusions over an 8 week period.The purpose of…

Read more